rosiglitazone has been researched along with thromboxane b2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Firuzi, O; Latina, V; Parmar, VS; Prasad, AK; Salemme, A; Saso, L; Togna, AR; Togna, GI | 1 |
| Bond, R; Cook, J; Gilkeson, G; Guyton, K; Halushka, P; Reilly, C | 1 |
| Akbiyik, F; Blumberg, N; Francis, CW; Gettings, KF; Phipps, RP; Ray, DM | 1 |
3 other study(ies) available for rosiglitazone and thromboxane b2
| Article | Year |
|---|---|
4-Methylcoumarin derivatives with anti-inflammatory effects in activated microglial cells.
Topics: Animals; Anti-Inflammatory Agents; Coumarins; Cyclooxygenase 2; Dinoprostone; Inflammation; Inflammation Mediators; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Rats; Thromboxane B2; Tumor Necrosis Factor-alpha | 2014 |
Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Topics: Animals; Cyclopentanes; DNA-Binding Proteins; Enzyme Activation; Epoprostenol; I-kappa B Proteins; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-KappaB Inhibitor alpha; Nitric Oxide; Phosphorylation; Prostaglandin D2; Protein Processing, Post-Translational; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Thromboxane B2; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.
Topics: Adenosine Triphosphate; Blood Platelets; Bone Marrow Cells; CD40 Ligand; Cell Line; DNA-Binding Proteins; Gene Expression; Humans; Hypoglycemic Agents; Megakaryocytes; Platelet Aggregation; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Thromboxane B2; Transcription Factors | 2004 |